Our results demonstrate that RBM3 expression was unrelated to p53 expression in all esophageal cancer samples (p = 0.1098), as well as the subset of EACs (p = 0.8339) and ESCCs (p = 0.1466). Here, RBM3 is linked to esophageal cancer.